Abstract
We describe a case of traumatic endophthalmitis due to Scedosporium apiospermum that was successfully treated with a combination of intravitreal and systemic voriconazole. A high dose of 200 μg was used intravitreally without any apparent complications. A brief overview of voriconazole use for treatment of ocular infections is presented, and a comparison is made with antifungal agents traditionally used in ophathalmology.
References
Sabo JA, Abdel-Rahman SM (2000) Voriconazole: a new triazole antifungal. Ann Pharmacother 34:1032–1043
Muijsers RBR, Goa KL, Scott LJ (2002) Voriconazole in the treatment of invasive Aspergillosis. Drugs 62:2655–2664
Gao H, Pennesi ME, Shah K et al (2004) Intravitreal voriconazole. An electrographic and histopathologic study. Arch Ophthalmol 122:1687–1692
Marco F, Pfaller MA, Messar SA, Jones RN (1998) Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. Med Mycol 36:433–436
Ghannoum MA, Kuhn DM (2002) Vorcionazole: better chances for patients with invasive mycoses. Eur J Med Res 7:242–256
Espinel-Ingroff A, Boyle K, Sheehan DJ (2001) In vitro antifungal activities of voriconazole and reference against as determined by NCCLS methods: review of the literature. Mycopathologia 150:101–115
Hariprasad SM, Mieler WF, Holz ER et al (2004) Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol 122:42–47
Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli W (2007) Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother 51:239–244
Axelrod AJ, Peyman GA, Apple DJ (1973) Toxicity of intravitreal injection of amphotericin B. Am J Ophthalmol 76:578–583
Pfaller MA, Messar SA, Hollis RJ et al (2002) In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob Agents Chemother 46:1723–1727
Reis A, Sundmacher R, Tintelnot K et al (2000) Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole. Br J Ophthalmol 84:932–933
Garbino J, Ondrusova A, Baligvo E, Lew D, Bouchuiguir-Wafa K, Rohner P (2002) Successful treatment of Paecilomyces Iliacinus endophthalmitis with voriconazole. Scand J Infect Dis 24:701–703
Abraham OT, Manavathu EK, Cuthright JL et al (1999) In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole and amphotericin B. Diagn Microbiol Infect Dis 33:7–11
Rubin ZA, Somani J (2004) New options for the treatment of invasive fungal infections. Semin Oncol 31(2):91–99
Kim JE, Perkins SL, Harris GJ, Milwaukee W (2003) Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection. Arch Ophthalmol 121:735–737
Scott IU, Cruz-Villegas V, Flynn HW, Miller D (2004) Delayed onset bleb-associated endophthalmitis caused by Lecythophoria mutabilis. Am J Ophthalmol 137:583–585
Nulens E, Eggink C, Rijs AJMM, Wesseling P, Verweij PE (2003) Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole. J Clin Microbiol 41(5):2261–2264
Nehemy MB, Vasconcelos-Santos DV, Torqueti-Costa L, Magalhaes E (2006) Chronic endophthalmitis due to Verticillium species after cataract surgery treated (or managed) with pars plana vitrectomy and oral and intravitreal voriconazole. Retina 26:225–227
Figueroa M, Fortun J, Clement A, Fernandez de Arevalo B (2004) Endogenous endophthalmitis caused by Scedosporium apiospermum treated with voriconazole. Retina 24:319–320
Kramer M, Kramer M, Blau H et al (2006) Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis. Ophthalmology 113:1184–1186
Sen P, Gopal L, Sen PR (2006) Intravitreal voriconazole for drug resistant fungal endophthalmitis. Case Ser Retina 26:935–939
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zarkovic, A., Guest, S. Scedosporium apiospermum traumatic endophthalmitis successfully treated with voriconazole. Int Ophthalmol 27, 391–394 (2007). https://doi.org/10.1007/s10792-007-9095-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-007-9095-0